Following a consultative meeting with the Centers for Disease Control and Prevention (CDC), and the District Tuberculosis and Leprosy Coordinator (DTLC), MFK conducted a baseline assessment of all the government health centers in Ugenya district, during which the assessment team identified 9 out of 17 health facilities that were not capable of carrying out AAFB microscopy for Tuberculosis screening. In 2010 August the organization facilitated a sensitization session for clinicians and sample transporters from all the 9 facilities that focused on sample (sputum) collection, packaging and safe transportation to the central laboratory where they are then processed. It was after this sensitization that the TB sample transport network was officially launched in November 2010 to stop movement of clients to and from the central lab.
Other preparatory activities included procuring cooler boxes for sputum transportation, distributing them to the facilities, and developing a schedule containing specific days when the facilities would bring in their sputum samples
Sample transporters are volunteers who are facilitated to transport samples for AAFB microscopy to the central lab in MFK and documented results from the central lab to the health facility.
The In-charge of the central lab at MFK and the District Medical Laboratory Technologist (DMLT) provide monthly supportive supervision and on job training (OJT) to the clinicians and sample transporters to ensure continuous quality improvement (CQI) of the TB sample transport network.
MFK also carries out internal quality control on a daily basis and external quality assurance (EQA) on a quarterly basis. The EQA is performed by the district medical laboratory technologist in SDH for the AAFB microscopy slides in a continued effort to improve healthcare in Ugenya district.